Loading clinical trials...
Loading clinical trials...
The main objective of this study is to compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with Major Depressive Disorder.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more
NCT07360600 · Parents, Children With Disabilities, and more
NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression
NCT07227454 · Depressive Disorder, Major
NCT06843187 · Major Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric Disorder
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions